Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsApi manufacturing facility

    Api Manufacturing Facility

    Jump to

    • API maker Granules Pharma simplifies structure involving US subsidiaries

      The exercise is aimed at reducing legal entities and simplify operating structure, said Granules Pharma, and the plan is expected to reduce the number of legal entities, simplify operational structures, and create a unified holding structure. The management said the move will not result in any change in the ownership of the subsidiaries.

    • API facility to boost revenue by 5-10%: Nectar Lifesciences

      Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executive director at Nectar Lifesciences, in an interview to CNBC-TV18, said the API manufacturing facility is likely to boost the company’s revenues by 5-10%.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347